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012.12.00Abstract Benign Joint Hypermobility Syndrome (BJHS) is a major source of morbidity in children
and adolescents. Due to fatigue and pain, activities of daily living may be limited.
Aim of the work: To investigate the relationship between fatigue and health related quality of life
in adolescents with BJHS.
Patients and methods: Thirty adolescents with BJHS and 30 controls were enrolled in the study.
All participants were subjected to clinical and laboratory assessment to exclude other causes of fati-
gue. All were requested to complete self assessment Pediatric Quality of Life (PedsQL) and multi-
dimensional fatigue scale questionnaires. Pain was assessed by Visual Analogue Scale (VAS).
Results: Compared to healthy adolescents, patients with BJHS had a signiﬁcant lower total score
for PedsQL scale (52.56 ± 8.40 and 87.63 ± 4.68 for patients and controls respectively, p< 0.001)
and a signiﬁcant lower total score for multidimensional fatigue scale (66.09 ± 13.05 and
91.32 ± 3.97 for patients and controls respectively, p< 0.001). General and cognitive fatigue that
accompanied BJHS, were the only signiﬁcant predictors of lower health related quality of life in
patients’ group. Among patients with BJHS; general fatigue was a signiﬁcant predictor for emo-
tional and social function impairment, while cognitive fatigue was a signiﬁcant predictor for school
function reduction. Total multidimensional fatigue scale score, general and cognitive fatigue were
predictors of physical function impairment in patients and controls. VAS was highly correlated
to PedsQL (r= 0.88, p=<0.001) and multidimensional fatigue (r= 0.99, p=<0.001)
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Benign Joint Hypermobility Syndrome (BJHS) is an under
diagnosed heritable connective tissue disorder, characterized
by generalized joint hypermobility and a wide range of
visceral, pelvic, neurologic, and cognitive dysfunctions. The
syndrome is associated with deterioration of quality of life
mainly due to the manifested pain and fatigue [1]. Adib et al.
concluded that the delay in diagnosis of BJHS results in poor
control of pain and fatigue and disruption of normal home life,
schooling and physical activities. Knowledge of the diagnosis
and simple interventions are likely to be highly effective in
reducing the morbidity and cost to the health and social
services [2].
Fatigue in BJHS appears as the result of multiple factors,
including muscle weakness, respiratory insufﬁciency, unre-
freshing sleep, dysautonomia, intestinal malabsorption, reac-
tive depression/anxiety, and excessive use of analgesics [1].
Fatigue has been deﬁned as an overwhelming sense of
tiredness, lack of energy, and feeling of exhaustion [3]. Muscu-
loskeletal disorders, including BJHS, are in general character-
ized by pain and fatigue with other physical disorders,
leading to decreased quality of life and economic burdens to
society [4]. Reviewing the medical literature, few studies focus-
ing on fatigue and quality of life in BJHS were available. How-
ever, Murray and Woo investigated the burden of fatigue in
children with BJHS in 2001 and reported that BJHS is a major
source of morbidity in children and due to fatigue; activities of
daily living, physical and sports activities may be limited [5].
One method of assessing the impact of a chronic illness on
the daily life of children is to measure the health related quality
of life. A comprehensive and multidimensional construct is the
Pediatric Quality of Life inventory core scales (PedsQL); it ad-
dresses an individual’s subjective perception of functioning
across multiple domains, including physical, emotional, social,
and school functioning [6]. The PedsQL generic core scales and
multidimensional fatigue scale signiﬁcantly distinguished be-
tween pediatric patients with ﬁbromyalgia and healthy chil-
dren [7].
Except for the recognized effectiveness of physiotherapy for
some musculoskeletal features, there are no standardized
guidelines for the assessment and treatment of pain and fatigue
in BJHS [1]. However, management is more or less similar to
other conditions characterized by fatigue. Multidisciplinary
treatment combining graded exercise therapy, cognitive behav-
ioral therapy and pharmacological treatment has shown short-
term improvements [8].
Fatigue proved to be an important, but still neglected factor
in BJHS treatment; the current study stressed on this symptom
in order to further strengthen the awareness that fatigue is a
serious aspect of the disease with far reaching consequences
on the person’s daily life. Because it turned out that fatigue
– besides pain – is one of the most annoying symptom to han-
dle in patients with rheumatic diseases [9];new knowledgeabout the relationship between fatigue and psychological and
physical functioning might help to inform about new strategies
and to improve existing treatments to combat fatigue.
The aim of the present study was to investigate the relation-
ship between fatigue and health related quality of life in ado-
lescents with BJHS.2. Patients and methods
A cross sectional design was employed in the current study,
which was carried out by performing a single clinical evaluation
using the same standardized protocol to all the study subjects.
The study was conducted in the period between January
2012 and June 2012 in the Ain Shams University and Suez Ca-
nal University hospitals. The study population included 30
adolescent patients (12–18 years) with BJHS as diagnosed by
applying the Brighton criteria (after calculating the Beighton
score), in addition to 30 healthy control who were age and
sex matched to the studied patients. An adolescent was deﬁned
as normal after clinical examination and based on declaration
by parents. The patients and control groups were recruited
from the pediatrics and the rheumatology clinics.2.1. Clinical assessment
The Beighton score consists of 5 maneuvers (total score = 9):
– Opposition of the thumb to the volar aspect of the ipsilat-
eral forearm (1 point for left; 1 for right).
– Passive dorsiﬂexion of the ﬁfth metacarpal joint toP90 (1
point for left; 1 point for right).
– Hyperextension of the elbow to P10 (1 point for left; 1
point for right).
– Placing of hands ﬂat on the ﬂoor without bending knees (1
point).
– Hyperextension of the knee toP 10 (1 point for left; 1
point for right).
The Brighton criteria include:
Major Criteria
 A Beighton score of 4/9 or greater.
 Arthralgia for longer than 3 months in more than 4 joints.
Minor Criteria
 A Beighton score of 1, 2 or 3/9.
 Arthralgia > 3 months in 1-3 joints or back pain > 3 -
months, spondylosis/spondylolisthesis.
 Dislocation/subluxation in > 1 joint, or 1 joint more than
once.
 Soft tissue rheumatism (eg: epicondylitis, tenosynovitis,
bursitis)>3 lesions.
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upper/lower segment ratio less than 0.89, arachnodactyly,
positive Steinberg/wrist signs).
 Abnormal skin: striae, hyper-extensible skin.
 Eye signs: drooping eyelids or myopia or antimongoloid
slant.
 Varicose veins or hernia or uterine/rectal prolapse.
Diagnosis of BJHS is conﬁrmed in the presence of two ma-
jor criteria, or one major and two minor criteria, or four minor
criteria [10].
All adolescents underwent clinical assessment in the form of
general medical history taking and examination with stress on
the musculoskeletal system. Exclusions included acute illness
such as common cold and gastroenteritis, chronic diseases
(diabetes, renal impairment, malignancy etc) and other rheu-
matic diseases including ﬁbromyalgia and chronic fatigue syn-
drome (CFS). Following laboratory assessment, any patient
who showed any abnormal result was also excluded.
A written consent was obtained from parents of all partic-
ipants. All patients and control groups completed a self assess-
ment pediatric quality of life [11], and multidimensional
fatigue scale [12] questionnaires which were translated into
Arabic language. Regarding the validity of the translation pro-
cess, the authors and other expert concluded that it is face va-
lid. For test- retest reliability, the questionnaires were tested on
a group of normal children (n= 20) and then repeated (r coef-
ﬁcient was 0.8).The study was approved by the local ethics
committee and complies with the Helsinki declaration.2.2. Measures
Health-related quality of life was assessed using the Pediatric
Quality of Life inventory (PedsQL) generic core scales, version
4.0 [11], while for fatigue, the multidimensional fatigue scale
[12] was employed. The PedsQL generic core scales version
4.0 consists of 23 items which can be completed independently
by adolescents. It includes four domains that measure physical
functioning, emotional functioning, social functioning and
school functioning. The instructions ask how much of a prob-
lem each item has been during the past one month. A 5-point
response scale is utilized (0 = never a problem; 1 = almost
never a problem; 2 = sometimes a problem; 3 = often a prob-
lem; 4 = almost always a problem).Items are reverse-scored
and linearly transformed into a 0–100 scale (0 = 100,
1 = 75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate
better HRQoL. Scale Scores are computed as the sum of the
items divided by the number of items answered. The minimum
total score is 0 and the maximum is 100 for each domain. The
multidimensional fatigue scale includes 3 domains; general fa-
tigue, sleep/ rest fatigue and cognitive fatigue. It consists of 18
items. The format, instructions, scale and scoring method are
identical to the PedsQL 4.0 generic core scales, with higher
scores indicating better HRQoL (fewer problems or symp-
toms) .The minimum total score is 0 and the maximum is
100 for each domain.
General fatigue has been deﬁned as an overwhelming sense
of tiredness, lack of energy, and feeling of exhaustion [3]. Cog-
nitive fatigue was deﬁned as a failure to sustain attention that
requires self-motivation to optimize performance [13].Sleep /
rest fatigue as deﬁned from the multidimensional fatigue scaleincludes any of increased period of sleep, ﬁnding it hard to
sleep through night, taking a lot of naps and spending a lot
of time in bed.
Adolescents independently completed their questionnaires.
Assistance by the physician was provided if required.
2.3. Visual analogue scale (VAS) pain intensity assessment
The VAS intensity rating consisted of a 100 mm horizontal line
with the end points no pain and worst pain. The far left end
indicates ‘No pain’ and the far right end indicates ‘Worst pain
ever’. Study participants were asked to make a mark on the
line that represented their current pain intensity, and the
VAS pain intensity level was scored by measurement in milli-
meters of the distance from the no pain end of the line to
the point marked by the patient.
2.4. Laboratory assessment
Laboratory assessment for adolescents with BJHS included
complete blood count (CBC), erythrocyte sedimentation rate
(ESR), C reactive protein (CRP), anti nuclear antibody
(ANA), IgM rheumatoid factor, anticitrulline peptide
antibody (ACPA), serum calcium, alanine aminotransferase
(ALT),aspartate aminotransferase (AST), serum creatinine
and thyroid stimulating hormone (TSH).
Statistical analysis: The data were collected and processed
to a personal computer IBM compatible. Data were analyzed
with the aid of the program statistical package for social sci-
ence (SPSS) 10 for windows. The data were tested for normal-
ity by using Shapiro-Wilk test (P> 0.05) for all variables. So,
parametric tests (t-test and regression analyses) were used for
the continuous variables. Pearson Chi square test was used
to compare categorical variables.
Multiple linear regression analyses were conducted between
the total PedsQL score and its domains as dependent variables
and a list of independent variables to identify the predictors of
the quality of life. The independent variables included patients’
age, gender, body mass index (BMI), type of the study group,
VAS score, multidimensional fatigue scale total and domains,
hemoglobin level, ESR, serum calcium, TSH, creatinine, ALT,
and AST.
3. Results
The study enrolled 30 adolescents with BJHS (17 males and 13
females) and 30 normal adolescents (15 males and 15 females)
.Both groups were gender matched (X2 = 0.268, p= 0.605)
and age matched (Table 1).
We excluded 2 patients suspected to have ﬁbromyalgia; the
speciﬁc tender points for the syndrome were detected on exam-
ination .Following laboratory assessment 7 patients were ex-
cluded; 3 for high ESR, 2 for high CRP and 2 for severe
iron deﬁciency anemia.
The disease duration ranged from 3 to 13 months
(mean ± SD= 7.87 ± 2.24). Regarding the principal com-
plaint of the patients, 17/30 [9 males (30%) and 8 females
(26.67%)] presented with the complaint of fatigue, 7/
30(23.34%) with arthralgia (knees in 6 and ankles in 1), 4/30
(13.34%) with low back pain and 2/30 (6, 67%) with feet pain.
None of the studied patients had symptoms (other than fati-
Table 1 Comparison between BJHS and control groups regarding demographic and laboratory data.
Patients n= 30 mean ± SD Control n= 30 t p
Age (years) 13.8 ± 1.9 14 ± 0.8 0.51 0.68
BMI (Kg/m2) 23.83 ± 4.11 24 ± 4.06 0.16 0.88
TLC (·103/mm3) 7.01 ± 1.66 7.1 ± 1.81 0.19 0.85
RBC count (·106/mm3) 4.84 ± 0.39 4.84 ± 0.43 0.03 0.98
Platelet count (·103/mm3) 336.7 ± 54.24 323.6 ± 52.89 0.95 0.35
Hemoglobin (·103/mm3) 13.84 ± 1.17 14.17 ± 1.26 1.06 0.29
ESR (mm/h) 14.17 ± 3.97 13.7 ± 3.04 0.51 0.61
ALT (IU/L) 20.93 ± 5.64 18.53 ± 7.78 1.37 0.18
AST (IU/L) 18.77 ± 4.62 18.53 ± 7.22 0.15 0.88
Creatinine (mg/dL) 0.68 ± 0.17 0.63 ± 0.18 1.03 0.31
TSH (lIU/L) 2.96 ± 0.62 3.13 ± 0.76 0.95 0.35
Calcium (mg/dL) 9.47 ± 0.54 9.54 ± 0.57 0.54 0.59
BJHS: benign joint hypermobility syndrome; TLC: total leukocyte count; RBCs: red blood cells; ESR: erythrocyte sedimentation rate; ALT:
alanine aminotransferase; AST: aspartate aminotransferase; TSH: thyroid stimulating hormone; SD: standard deviation.
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of the patients had history consistent with joint dislocation
or joint subluxation. History of a previous attack of ankle
sprain was found in 5/30 patients, otherwise none of the pa-
tients gave history consistent with arthritis, and on musculo-
skeletal examination none showed signs of arthritis. None of
the included patients had any associated or underlying connec-
tive tissue disease dysplasia. None of the patients was regularly
using analgesics, and at the time of inclusion in the study, none
of the patients was on analgesics for symptom relief. Patients
were requested to stop it (if any) for two weeks prior to inclu-
sion in the study. None of the included healthy controls com-
plained of fatigue or any other musculoskeletal manifestations.
Fig. 1 illustrates 4/5 maneuvers of the Beighton score as ob-
tained from our BJHS patients.
CRP, ANA, IgM rheumatoid factor, and ACPA were neg-
ative in all enrolled subjects. Results of the other laboratory
investigations are illustrated in Table 1.
All items of the PedsQL and the multidimensional fatigue
assessment questionnaires were completed by patients and
controls. The mean values of the 4 domains of the PedsQL
questionnaire, the 3 domains of the multidimensional fatigue
scale and VAS score in patients compared to controls are illus-
trated in Table 2. Adolescents with BJHS recorded consider-
ably lower scores for all the 7 items of both scales
(p< 0.001). Their lowest scores were in the school function
and the general fatigue domains. VAS score was signiﬁcantly
higher in patients’ group.
The strength of the univariate relationships between the
total PedsQL scores and the predictor variables are shown in
Table 3. General fatigue domain, cognitive fatigue domain
and type of the study group were the signiﬁcant independent
predictors of the total PedsQL score. Also, the total score of
the multidimensional fatigue scale was a signiﬁcant indepen-
dent predictor of the PedsQL total score (t= 4.828, p<
0.001). There was a negative linear association between type
of the study group and the PedsQL total score. In other words,
the scores were signiﬁcantly higher in the control group than
the patients’ group.
The total multidimensional fatigue scale score was a signif-
icant predictor for the physical function domain score
(t= 7.812, p< 0.001). On further multiple linear regression
analysis for other predictors of the physical function domain,general fatigue and cognitive fatigue scores were also found
to be signiﬁcant predictors (Table 4). There was no association
between the type of the study group and physical domain score
i.e. there was no signiﬁcant difference between patients and
controls. Table 4 shows that the signiﬁcant independent pre-
dictors of school function domain were type of the study group
and the cognitive fatigue score. There was a negative linear
association between the study group and the emotional, social
and school function domain scores i.e. the scores were signiﬁ-
cantly higher in the control group than the patients’ group.
The only signiﬁcant predictors of emotional function do-
main were the type of the study group (t= 7.22, p< 0.001)
and the general fatigue score (t= 3.05 p= 0.004), while the
only signiﬁcant independent predictors of social function do-
main were type of the study group (t= 11.95, p< 0.001)
and the general fatigue score (t= 3.27 p= 0.002).Data are
illustrated in Table 5.
There was a signiﬁcant correlation between VAS and the
PedsQL and the multidimensional fatigue scales and their do-
mains in the BJHS group (Table 6). However, in the regression
models (Tables 4 and 5) VAS was not a predictor of PedsQL
and its domains; the signiﬁcantly high bivariate correlations
between the dependent variables (BJHS, VAS and fatigue)
are the cause of amelioration of the effect of VAS when in-
cluded in the regression models.
4. Discussion
In discussion the present study revealed that health related
quality of life is diminished in adolescents with BJHS com-
pared with age and gender-matched controls. Patients with
BJHS reported an impact of disease on emotional, social and
school function domains of the PedsQL. Fatigue which accom-
panies BJHS is a signiﬁcant predictor of the reduced health re-
lated quality of life in those patients. Pain was highly
correlated to fatigue and health related quality of life.
Dysautonomia is one of the extra-articular manifestations
in joint hypermobility syndrome. Symptoms related to the
autonomic nervous system, such as syncope and presyncope,
palpitations, chest discomfort, fatigue, and heat intolerance,
are more common among patients compared to controls [14].
In our series fatigue was the only assessed of these symptoms,
and none of the patients gave history suggestive of other dys-
a b
c
d
Figure 1 Maneuvers of the Beighton score. (a) opposition of the thumb to the volar aspect of the ipsilateral forearm, (b) passive
dorsiﬂexion of the ﬁfth metacarpal joint to >90, (c) hyperextension of the elbow joint to >10 and (d) hyperextension of the knee joint to
>10.
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nomic nervous system manifestations was beyond the scope of
our aim.
In the current study, fatigue along with BJHS was the only
signiﬁcant predictors of the diminished health related quality
of life in the patients’ group. This association was proved for
other chronic illnesses affecting the pediatric population.
Among survivors of childhood cancer, an inverse relationship
exists between symptoms of fatigue and a patient’s positive
perception of health related quality of life. Notably, survivors
who did not report fatigue were comparable to healthy con-
trols on measures of functioning [15]. In children with primar-
ily inactive inﬂammatory bowel disease (IBD), fatigue wassigniﬁcantly higher and health related quality of life was signif-
icantly lower than in healthy controls. Results among children
with IBD were comparable to children with rheumatologic dis-
eases and cancer [16].
On history taking and clinical examination patients sus-
pected to have any other cause of fatigue were excluded. In
addition, patients with abnormal laboratory results were ex-
cluded, and no difference was recorded between the enrolled
patients and controls regarding all laboratory results. So, it
is likely that the recorded fatigue in our series was related to
BJHS and not to other diseases. Furthermore, multiple regres-
sion analysis revealed that age, gender, BMI and laboratory re-
sults were not predictors of any of the PedsQL domains while
Table 2 Comparison between BJHS and control groups regarding scores of the domains of PedsQL and multidimensional fatigue
scales and VAS score.
Patients’ group n= 30 mean ± SD Control group n= 30 t p
PedsQL
Physical 54.58 ± 18.02 81.77 ± 9.18 7.37 <0.001
Emotional 56.17 ± 11.27 89.67 ± 3.46 15.56 <0.001
Social 55.67 ± 7.16 89.33 ± 5.04 21.06 <0.001
School 43.83 ± 20.71 89.83 ± 5.80 11.72 <0.001
Total 52.56 ± 8.40 87.63 ± 4.68 19.98 <0.001
Multidimensional fatigue scale
General 63.75 ± 19.08 88.47 ± 5.65 6.80 <0.001
Sleep/rest 73.89 ± 17.44 92.77 ± 5.13 5.69 <0.001
Cognitive 66.95 ± 15.12 92.64 ± 4.05 8.99 <0.001
Total 66.09 ± 13.05 91.32 ± 3.97 10.14 <0.001
VAS score 33.90 ± 13.04 8.57 ± 4.06 10.16 <0.001
BJHS: benign joint hypermobility syndrome; VAS: visual analogue scale.*p value is statistically signiﬁcant at <0.05.
Table 3 Multiple regression analysis: predictors of the total
PedsQL score in BJHS group.
Standardized Beta coeﬃcients t p
Constant 2.05 0.05
Age 0.04 1.00 0.32
Gender 0.03 0.85 0.40
BMI 0.01 0.27 0.79
BJHS 0.61 9.08 0.00
General fatigue 0.34 4.29 0.00
Sleep/rest fatigue 0.02 0.20 0.84
Cognitive fatigue 0.12 2.07 0.04
VAS score 0.49 .38 0.71
ESR 0.06 1.54 0.13
Hemoglobin level 0.03 0.74 0.46
Serum calcium 0.02 0.46 0.65
TSH 0.03 0.72 0.48
ALT 0.05 0.85 0.40
AST 0.00 0.09 0.93
Creatinine 0.01 0.23 0.82
Dependent variable: PedsQL total score. BJHS: benign joint
hypermobility syndrome; BMI: body mass index; VAS: visual
analogue scale; ESR: erythrocyte sedimentation rate; TSH: thyroid
stimulating hormone; ALT: alanine aminotransferase; AST:
aspartate aminotransferase.
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gue is the cause of the impaired health related quality of life
recorded in our series.
Fatigue is a critical contributor to the impact of chronic ill-
ness on multiple domains of functioning. In juvenile rheuma-
toid arthritis (JRA) maintenance of a social life is negatively
inﬂuenced by physical fatigue, reduced activity, pain and
depressive symptoms [17]. Furthermore, in those patients fati-
gue reduces the patients’ self-esteem; heightens irritability, and
feelings of loss of control [9].In the current study, BJHS was
the signiﬁcant predictor for emotional, social and school func-
tion impairment. In addition, general fatigue was a predictor
for emotional and social function impairment; while cognitive
fatigue was the predictor for school function impairment. This
denotes that fatigue which associates BJHS is a direct cause of
impairment of multiple domains of function. In chronic dis-
eases characterized by relapse and remission, fatigue is evenmanifested in the remission periods. In patients with IBD, in
remission, fatigue is an important feature. Both in Crohn’s dis-
ease and in ulcerative colitis, fatigue determined health related
quality of life independent of disease activity or anemia [18].
Subsequent studies also proved that fatigue is associated with
reduction of health related quality of life scores in IBD, where
the physical domains are particularly affected [19]. This could
imply that in patients with BJHS, fatigue could be the major or
even the only complaint. This was the case in 17 out of our 30
patients.
Delay in diagnosis of BJHS results in poor control of pain
and fatigue and disruption of normal home life, schooling and
physical activities [2]. Once symptoms of cognitive or neuro-
psychiatric nature are established, cognitive, behavioral, emo-
tional, physiological and social factors are thought to work
together to perpetuate those symptoms [20]. In our patients,
school function was the most affected domain. Cognitive fati-
gue which associates BJHS was a signiﬁcant predictor of
school function impairment. Accordingly, early recognition
of cognitive fatigue symptoms could be beneﬁcial in preventing
deterioration at the school level through cognitive rehabilita-
tion procedures. In chronic fatigue syndrome (CFS), evidence
of clear cognitive impairment independent of psychopathology
deﬁcits remain even when factors associated with performance
impairments are taken into consideration. Improvements or
recovery from the illness was postulated to be accompanied
by improvements in cognition [21].
Fatigue, mainly general and cognitive, was a predictor for
the impaired physical function in patients and controls. The re-
corded fatigue in controls; though is of lower magnitude, in
not surprising. Approximately one third of normal healthy
adolescents experience substantial fatigue four or more times
a week [22]. However, the present study recorded a statistically
signiﬁcant difference between BJHS patients and controls in
PedsQL and fatigue scores. This alleviates the possibility that
fatigue in adolescents with BJHS is of the same frequency
and severity found in normal adolescents.
More than three-quarters of Ehlers–Danlos Syndrome
(EDS) patients suffer from severe fatigue and the possible
determinants of fatigue are sleep disturbances, concentration
problems, social functioning, self-efﬁcacy concerning fatigue,
and pain severity [23]. Of special interest is the Ehlers–Dan-
los Syndrome hypermobility type (EDS-HT) which is closely
Table 4 Multiple regression analysis: predictors of the physical function and school function domains in BJHS group.
Physical function domain score School function domain score
Standardized Beta coeﬃcients t p Standardized Beta coeﬃcients t p
Constant 1.42 0.16 0.50 0.62
Age 0.09 1.72 0.09 0.06 0.69 0.49
Gender 0.04 0.72 0.48 0.09 1.08 0.29
BMI 0.06 1.14 0.26 004 0.45 0.65
BJHS 0.01 0.14 0.89 0.60 4.17 0.00
General fatigue 0.63 6.13 0.00 005 0.31 0.76
Cognitive fatigue 0.20 2.57 0.01 0.33 2.61 0.01
Sleep/Rest fatigue 0.19 1.92 0.06 0.12 0.71 0.48
VAS score 2.12 1.26 0.22 1.34 0.49 0.63
ESR 0.10 1.86 0.07 0.07 0.84 0.40
Hemoglobin level 0.05 0.88 0.38 0.10 1.07 0.29
Serum calcium 0.03 0.52 0.61 0.04 0.49 0.63
TSH 0.01 0.23 0.82 0.07 0.81 0.42
ALT 0.15 1.71 0.09 0.01 0.09 0.93
AST 0.02 0.30 0.77 0.01 0.13 0.90
Creatinine 0.00 0.05 0.96 0.02 0.22 0.83
Dependent variable: PedsQL physical function and school function domain scores. BJHS: benign joint hypermobility syndrome; BMI: body
mass index; VAS: visual analogue scale; ESR: erythrocyte sedimentation rate; TSH: thyroid stimulating hormone; ALT: alanine aminotrans-
ferase; AST: aspartate aminotransferase.
Table 5 Multiple regression analysis: predictors of the emotional function and social function domains in BJHS group.
Emotional function domain score Social function domain score
Standardized Beta coeﬃcients t p Standardized Beta coeﬃcients t p
Constant 3.37 0.002 3.34 0.002
Age 0.06 1.08 0.29 0.05 1.16 0.25
Gender 0.04 0.66 0.52 0.00 0.06 0.95
BMI 0.02 0.37 0.71 0.06 1.52 0.14
BJHS 0.75 7.22 0.000 0.86 11.95 0.000
General fatigue 0.37 3.05 0.004 0.28 3.27 0.002
Cognitive fatigue 0 0.98 0.33 0.11 1.73 0.09
Sleep/Rest fatigue 0.06 0.50 0.62 0.11 1.73 0.09
VAS score 2.17 1.10 0.28 0.06 0.04 0.97
ESR 0.02 0.32 0.75 0.02 0.48 0.64
Hemoglobin level 0.01 0.19 0.85 0.03 0.54 0.59
Serum calcium 0.03 0.42 0.67 0.04 0.96 0.34
TSH 0.00 0.06 0.96 0.00 0.05 0.96
ALT 0.02 0.19 0.85 0.07 0.99 0.33
AST 0.00 0-.05 0.96 0.02 0.36 0.72
Creatinine 0.02 0.27 0.79 0.03 0.65 0.52
Dependent variable: PedsQL emotional function and social function domain scores. BJHS: benign joint hypermobility syndrome; BMI: body
mass index; VAS: visual analogue scale; ESR: erythrocyte sedimentation rate; TSH: thyroid stimulating hormone; ALT: alanine aminotrans-
ferase; AST: aspartate aminotransferase.
The impact of fatigue on health related quality of life in adolescents with benign joint hypermobility syndrome 83related, clinically, to BJHS [24]. Those patients manifest sig-
niﬁcant joint pain, joint dislocations, muscle cramps, tendini-
tis, fatigue and headache, and their health related quality of
life was reported as signiﬁcantly impaired [25]. The signiﬁ-
cant fatigue and impairment of quality of life elicited in
our BJHS group could provide some support to the notion
that both syndromes (EDS-HT and BJHS) share many of
the clinical manifestations; taking into consideration that
we did not study the factors reported to determine fatigue
in EDS.
Joint hypermobility is more common in patients with CFS
than in otherwise healthy children with common skin disor-
ders; signiﬁcantly more incident and prevalent CFS cases
had Beighton scores of P4 [26].The detected hypermobilityin CFS patients could be related to coexisting EDS [27],
although other studies argued such hypothesized association
[28]. In our study, patients suspected to have CFS were ex-
cluded and the direct cause of the signiﬁcant fatigue and qual-
ity of life impairment is BJHS.
Fatigue is prevalent among children with different rheu-
matic diseases and fatigue is strongly associated with increased
pain and decreased quality of life [29]. Preacher and Hayes [30]
proposed a mediation model for fatigue. They proposed that
fatigue functioned as a mediator between pain and overall
health related quality of life based on both self and proxy re-
ports. Later, a similar mediation model was also proposed
where fatigue was hypothesized to mediate the effects of pain
on children’s health related quality of life, speciﬁcally their
Table 6 The correlation between visual analogue scale and
PedsQL and multidimensional fatigue scales in BJHS group.
VAS score
r p
BJHS 0.80* <0.001
PedsQL total score 0.88* <0.001
Physical function domain 0.88* <0.001
School function domain 0.72* <0.001
Social function domain 0.81* <0.001
Emotional function domain 0.78* <0.001
Multidimensional fatigue scale total score 0.99* <0.001
General fatigue 0.862* <0.001
Cognitive fatigue 0.75* <0.001
Sleep/Rest fatigue 0.84* <0.001
VAS: visual analogue scale; BJHS: benign joint hypermobility
syndrome.
* Correlation is signiﬁcant at <0.01 level (2-tailed).
84 O.A. Zekry et al.school functioning [31].In the present study, pain was more
signiﬁcant in BJHS group and was highly correlated to fatigue
and PedsQL. This result could support the postulated medita-
tional role of fatigue in the relationship between pain and the
overall health related quality of life.
Limitations of the study include the relatively small number
of the study population, so our results are considered prelimin-
ary. In addition, the study was limited to a deﬁnite age group
and it is not known if results could be applied to patients with
BJHS of all age groups. The cross sectional design does not
permit follow up of patients to evaluate for possible variation
of symptoms following different suggested interventions, also
the cross-sectional nature of the study does not permit for
any ﬁrm conclusion regarding the direction of causal relation-
ships to be made. Studies incorporating simultaneous assess-
ment of the other different factors, implicated as causes of
fatigue in BJHS, are expected to highlight the most important
ones for subsequent possible interventions.
The conclusion gained from the current study is that ado-
lescents with BJHS compared to controls have signiﬁcant fati-
gue that leads to reduced health related quality of life. Their
emotional, social and school function is disturbed because of
the manifested fatigue. Although physical function reduction
associated with total, general and cognitive fatigue occurred
both in patients and controls; impairment was greater in the
patients’ group. Pain was more signiﬁcant in BJHS group
and was correlated to both health related quality of life and
fatigue. Owing to the small number of patients enrolled, the
results of the present study are preliminary; the high
prevalence of fatigue in BJHS emphasizes the need for further
detailed prospective research to better understanding of its
etiology, course and management.
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